Spruce Biosciences, Inc banner

Intrinsic Value

The intrinsic value of Spruce Biosciences, Inc (SPRB) under the Base Case is USD per share. Compared with the current market price of 38 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SPRB Intrinsic Value

Our estimate of what one share is worth.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Intrinsic value for the past 5 years is hidden
Alert me when SPRB is below its intrinsic value
Today Hidden ·
Alternatives to SPRB

Fundamental Analysis

What Spruce Biosciences Does

Biotechnology Health Care

Spruce Biosciences is a development-stage biotechnology company that works on medicines for rare endocrine disorders, especially conditions tied to abnormal hormone production. Its main drug candidate has been tildacerfont, an oral medicine designed to treat congenital adrenal hyperplasia, a lifelong genetic disease that can cause the body to make too many stress hormones.

Headquarters
United States of America US
Employees
9
IPO date
Oct 9, 2020
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue SPRB Research

Decided on Spruce Biosciences? Get an email when SPRB reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one SPRB stock?

The intrinsic value for Spruce Biosciences, Inc (SPRB) under the Base Case is USD.

Is SPRB stock undervalued or overvalued?

Compared with the current market price of 38 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top